Risultati della ricerca - Markus Cornberg

Raffina i risultati
  1. 1
    Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity

    Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity di Markus Cornberg

    Pubblicazione 2006
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  2. 2
    Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability

    Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability di Markus Cornberg, Frank Tacke, Tom H. Karlsen

    Pubblicazione 2018
    Testo Testo
    Editorial
    Aggiungi alla lista
    Salvato in:
  3. 3
    EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients

    EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients di Markus Cornberg, Marı́a Buti, Christiane S. Eberhardt, Paolo Grossi, Daniel Shouval

    Pubblicazione 2021
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  4. 4
    Natural killer cells act as rheostats modulating antiviral T cells

    Natural killer cells act as rheostats modulating antiviral T cells di Stephen N. Waggoner, Markus Cornberg, Liisa K. Selin, Raymond M. Welsh

    Pubblicazione 2011
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  5. 5
    Guidance for Design and Endpoints of Clinical Trials in Chronic Hepatitis B—Report From the 2019 EASL‐AASLD HBV Treatment Endpoints Conference

    Guidance for Design and Endpoints of Clinical Trials in Chronic Hepatitis B—Report From the 2019 EASL‐AASLD HBV Treatment Endpoints Conference di Markus Cornberg, Anna Suk‐Fong Lok, Norah A. Terrault, Fabien Zoulim

    Pubblicazione 2019
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  6. 6
    Direct-Acting Antiviral–Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C

    Direct-Acting Antiviral–Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C di Julia Hengst, Christine S. Falk, Verena Schlaphoff, Katja Deterding, Michael P. Manns, Markus Cornberg, Heiner Wedemeyer

    Pubblicazione 2016
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  7. 7
    Systemic arterial blood pressure determines the therapeutic window of non‐selective beta blockers in decompensated cirrhosis

    Systemic arterial blood pressure determines the therapeutic window of non‐selective beta blockers in decompensated cirrhosis di Tammo Lambert Tergast, Markus Kimmann, H. Laser, Svetlana Gerbel, Michael P. Manns, Markus Cornberg, Benjamin Maasoumy

    Pubblicazione 2019
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  8. 8
    Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper

    Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper di Tobias Boettler, Philip N. Newsome, Mario U. Mondelli, Mojca Matičič, Elisa Cordero, Markus Cornberg, Thomas Berg

    Pubblicazione 2020
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  9. 9
    Private specificities of CD8 T cell responses control patterns of heterologous immunity

    Private specificities of CD8 T cell responses control patterns of heterologous immunity di Sung-Kwon Kim, Markus Cornberg, Xiaoting Z. Wang, Hong D. Chen, Liisa K. Selin, Raymond M. Welsh

    Pubblicazione 2005
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  10. 10
    Bile acid increase during bulevirtide treatment of hepatitis D is not associated with a decline in <scp>HDV RNA</scp>

    Bile acid increase during bulevirtide treatment of hepatitis D is not associated with a decline in <scp>HDV RNA</scp> di Katja Deterding, Cheng‐Jian Xu, Kerstin Port, Christopher Dietz‐Fricke, Xun Jiang, Benjamin Maasoumy, Markus Cornberg, Heiner Wedemeyer

    Pubblicazione 2023
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  11. 11
    Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection

    Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection di A. Wranke, Benjamin Heidrich, Katja Deterding, Katharina Luise Hupa‐Breier, J. Kirschner, Birgit Bremer, Markus Cornberg, Heiner Wedemeyer

    Pubblicazione 2023
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  12. 12
    Increased NK Cell Function After Cessation of Long-Term Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Is Associated With Liver Damage and HBsAg Loss

    Increased NK Cell Function After Cessation of Long-Term Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Is Associated With Liver Damage and HBsAg Loss di Christine L. Zimmer, Franziska Rinker, Christoph Höner zu Siederdissen, Michael P. Manns, Heiner Wedemeyer, Markus Cornberg, Niklas K. Björkström

    Pubblicazione 2018
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  13. 13
    Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity

    Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity di Benedikt Strunz, Julia Hengst, Katja Deterding, Michael P. Manns, Markus Cornberg, Hans‐Gustaf Ljunggren, Heiner Wedemeyer, Niklas K. Björkström

    Pubblicazione 2018
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  14. 14
    EASL Clinical Practice Guidelines on haemochromatosis

    EASL Clinical Practice Guidelines on haemochromatosis di Heinz Zoller, Benedikt Schaefer, Annick Vanclooster, Bill Griffiths, Edouard Bardou–Jacquet, Elena Corradini, Graça Porto, John Ryan, Markus Cornberg

    Pubblicazione 2022
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  15. 15
    Value and Kinetics of Virological Markers in the Natural Course of Chronic Hepatitis D Virus Infection

    Value and Kinetics of Virological Markers in the Natural Course of Chronic Hepatitis D Virus Infection di Lisa Sandmann, Valerie Ohlendorf, Alena Friederike Ehrenbauer, Birgit Bremer, Anke Kraft, Markus Cornberg, Katja Deterding, Heiner Wedemeyer, Benjamin Maasoumy

    Pubblicazione 2025
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  16. 16
    Memory of mice and men: CD8<sup>+</sup> T‐cell cross‐reactivity and heterologous immunity

    Memory of mice and men: CD8<sup>+</sup> T‐cell cross‐reactivity and heterologous immunity di Liisa K. Selin, Michael A. Brehm, Yuri N. Naumov, Markus Cornberg, Sung‐Kwon Kim, Shalyn C. Clute, Raymond M. Welsh

    Pubblicazione 2006
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  17. 17
    Treatment of Acute Hepatitis C with Interferon Alfa-2b

    Treatment of Acute Hepatitis C with Interferon Alfa-2b di Elmar Jaeckel, Markus Cornberg, Heiner Wedemeyer, Teresa Santantonio, Julika Mayer, M Zankel, Giuseppe Pastore, Manfred Dietrich, Christian Trautwein, Michael P. Manns

    Pubblicazione 2001
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  18. 18
    Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: A randomized open-label pilot study

    Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: A randomized open-label pilot study di Markus Cornberg, Johannes Hadem, Eva Herrmann, Frank Schuppert, Hartmut Schmidt, Markus Reiser, Oliver Marschal, Martín Steffen, Michael P. Manns, Heiner Wedemeyer

    Pubblicazione 2005
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  19. 19
    Drug–Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World Cohort

    Drug–Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World Cohort di Christoph Höner zu Siederdissen, Benjamin Maasoumy, Fiona Marra, Katja Deterding, Kerstin Port, Michael P. Manns, Markus Cornberg, David Back, Heiner Wedemeyer

    Pubblicazione 2015
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  20. 20
    Interferon‐free therapy of chronic hepatitis C with direct‐acting antivirals does not change the short‐term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis

    Interferon‐free therapy of chronic hepatitis C with direct‐acting antivirals does not change the short‐term risk for de novo hepatocellular carcinoma in patients with liver cirrhos... di F Mettke, Bernhard Schlevogt, Katja Deterding, A. Wranke, Andrea Smith, Kerstin Port, M P Manns, Arndt Vogel, Markus Cornberg, Heiner Wedemeyer

    Pubblicazione 2017
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: